Hashioka, Sadayuki <br/><br/>
Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity.  [electronic resource] 

 -  Experimental neurology  May 2009 
 - 177-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2430 
<br/><br/><label>Standard No.: </label>10.1016/j.expneurol.2009.02.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Pyridinylmethylsulfinylbenzimidazoles--pharmacology<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Humans<br/>Inflammation--chemically induced<br/>Interferon-gamma--toxicity<br/>Interleukin-6--metabolism<br/>Lansoprazole<br/>Microglia--drug effects<br/>Monocytes--drug effects<br/>Neuroblastoma<br/>Omeprazole--pharmacology<br/>Polysaccharides--toxicity<br/>Proton Pump Inhibitors--pharmacology<br/>Tumor Necrosis Factor-alpha--metabolism